Impel NeuroPharma to Report Third Quarter 2021 Financial Results on Monday, November 15, 2021
SEATTLE, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Impel NeuroPharma, Inc. (NASDAQ: IMPL), a commercial-stage biopharmaceutical company developing transformative therapies for...